Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Collaborative Drug Discovery in August, 2019 for $149,873.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43TR003022-01 | Phase I | 149,873 | August 15, 2019 | |||||||
A SBIR Phase II contract was awarded to Collaborative Drug Discovery in December, 2017 for $1,498,762.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44TR000185-04A1 | Phase II | 1,498,762 | December 6, 2017 | |||||||
A SBIR Phase I contract was awarded to Collaborative Drug Discovery in August, 2018 for $149,830.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43TR002527-01 | Phase I | 149,830 | August 1, 2018 | |||||||
A SBIR Phase II contract was awarded to Collaborative Drug Discovery in August, 2022 for $854,888.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44TR003022-02A1 | Phase II | 854,888 | August 17, 2022 | |||||||
A SBIR Phase II contract was awarded to Collaborative Drug Discovery in April, 2021 for $727,255.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44TR002699-02A1 | Phase II | 727,255 | April 10, 2021 | |||||||
A SBIR Phase I contract was awarded to Collaborative Drug Discovery in February, 2019 for $149,831.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43TR002699-01 | Phase I | 149,831 | February 1, 2019 | |||||||
A SBIR Phase II contract was awarded to Collaborative Drug Discovery in December, 2019 for $748,733.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44TR002528-02 | Phase II | 748,733 | December 19, 2019 | |||||||
A SBIR Phase I contract was awarded to Collaborative Drug Discovery in August, 2018 for $204,304.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43TR002528-01 | Phase I | 204,304 | August 1, 2018 | |||||||
A SBIR Phase II contract was awarded to Collaborative Drug Discovery in April, 2020 for $749,928.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44TR002527-02 | Phase II | 749,928 | April 1, 2020 | |||||||
A SBIR Phase II contract was awarded to Collaborative Drug Discovery in August, 2013 for $1,404,275.0 USD from the U.S. Department of Health & Human Services. | SBIR | 9R44TR000942-02 | Phase II | 1,404,275 | August 16, 2013 | |||||||
A SBIR Phase II contract was awarded to Collaborative Drug Discovery in May, 2015 for $1,490,826.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44TR000185-02 | Phase II | 1,490,826 | May 15, 2015 | |||||||
A SBIR Phase II contract was awarded to Collaborative Drug Discovery in April, 2017 for $1,499,475.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44TR000942-05 | Phase II | 1,499,475 | April 1, 2017 | |||||||
A SBIR Phase I contract was awarded to Collaborative Drug Discovery for $149,999.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43LM011152-01 | Phase I | 149,999 | ||||||||
A STTR Phase II contract was awarded to Collaborative Drug Discovery for $997,178.0 USD from the U.S. Department of Health & Human Services. | STTR | 2R42AI088893-02 | Phase II | 997,178 | ||||||||
A STTR Phase I contract was awarded to Collaborative Drug Discovery for $149,382.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41AI088893-01 | Phase I | 149,382 | ||||||||
A SBIR Phase I contract was awarded to Collaborative Drug Discovery for $149,997.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43TR000185-01A1 | Phase I | 149,997 | ||||||||
A STTR Phase I contract was awarded to Collaborative Drug Discovery for $255,221.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41AI108003-01 | Phase I | 255,221 |